Skip to main content
OpenTrials
Completed

NCT Number: NCT00543660

Descemet Stripping (Automated) Endothelial Keratoplasty (DSEK or DSAEK)

To evaluate the transplantation of a posterior corneal disc for the management of corneal endothelial disorders in Descemet Stripping Endothelial Keratoplasty (DSEK) or Descemet Stripping Automated Endothelial Keratoplasty (DSAEK).

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Netherlands Institute for Innovative Ocular Surgery

Rotterdam, 3071 AA, Netherlands

About this study

Please see above.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Corneal endothelial disorders

Exclusion criteria

  • N/A

Treatment and study plan

Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

Procedure

Other names: Descemet Stripping Endothelial Keratoplasty (DSEK), Please see www.niios.com

Primary outcomes

  1. Best spectacle corrected visual acuity

    Time frame: 1998 - 2018

Secondary outcomes

  1. Corneal endothelial cell density

    Time frame: 1998-2018

Sponsors and collaborators

Lead sponsor

Netherlands Institute for Innovative Ocular Surgery

Other

Collaborators

  • Amnitrans Eyebank Rotterdam
  • Melles CorneaClinic Rotterdam

Registry information

Acronym: DSAEK

Important dates

Study start
1998
Primary completion
2018
Study completion
2018
First posted
Oct 15, 2007
Registry last updated
Jan 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.